ARCHIVES

Drug Development: Herceptin Associated with 15 Deaths, Genentech Says

This article is from The Cancer Letter archive.

Vol. 26 No. 19 | May 12, 2000

Download PDF Visit The Full Archive

Related Articles

“Sloppy Work” May Invalidate Methylene Chloride Study; Contractor Hints NTP Pressured By Industry

October 14, 1983

NCI Appropriations Still Hung Up

September 30, 1977

CIDAC Bids Not Limited To Cancer Research Centers

January 17, 1975

NIH Sets Tuition Cost Policy For NRSA Grants

February 9, 1996

Research Triangles Lands Plant Drug Contract Renewal

April 9, 1976

Robert Young To Step Down As Fox Chase Cancer Center President in 2007.

September 29, 2006